跳至主要内容
临床试验/NCT02069743
NCT02069743已完成不适用

Pain Management in Cancer Patients Using a Mobile Application

Massachusetts General Hospital4 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2014年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
110
试验地点
4
主要终点
Pain symptoms using the Brief Pain Inventory

研究概览

简要总结

The investigators have developed a mobile application (for use on smart phones) to help cancer patients better manage cancer pain. This study is a randomized controlled trial to evaluate the effect of this mobile-based intervention. The investigators' hypothesis is that subjects randomized to the intervention group will have a reduction in pain and pain-related hospitalizations.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All adult patients, 18 years and above suffering from solid-organ cancer.
  • Diagnosed with moderate or severe cancer pain (i.e. pain intensity score of at least 4/10 on numeric rating scale (NRS)) at the Massachusetts General Hospital (MGH) Palliative Care Center, as determined by the patient's care provider at the MGH Palliative Care Center. Subjects do not need to experience a specific nature of pain for eligibility.
  • Patients must be ambulatory and not currently admitted to the hospital at time of enrollment.
  • Must have a smart phone and be willing to download the study application (Phase II only)
  • Must be able to read and speak English.

排除标准

  • Life expectancy less than 2-months as determined by the palliative care provider
  • Significant medical or psychiatric co-morbidities (other than depression or anxiety) or cognitive impediments that would prevent participant from being able to utilize the program
  • Known history of substance abuse
  • Patients currently on investigational therapies or other study protocols that may have an impact on pain intensity or quality of life which are main outcomes of this intervention.

结局指标

主要结局

Pain symptoms using the Brief Pain Inventory

时间窗: up to 8 weeks

The primary aim is to assess the effect of a tailored, multi-dimensional mobile-based intervention on the intensity of cancer pain in cancer patients with moderate to severe pain.

次要结局

  • Patient-related barriers to pain management using the Barriers Questionnaire-II(up to 8 weeks)
  • Engagement as tracked by the app(up to 8 weeks)
  • Anxiety symptoms using the Generalized Anxiety Disorder (GAD-7)(up to 8 weeks)
  • Pain related hospitalization from the Electronic Health Record(up to 8 weeks)
  • Quality of life using the Functional Assessment of Cancer Therapy (FACT-G)(up to 8 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mihir M. Kamdar,M.D.

Attending Physician

Massachusetts General Hospital

研究点 (4)

Loading locations...

相似试验